Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glucuronidase, beta pseudogene 11 (GUSBP11) is a processed human pseudogene located on chromosome 22 that is transcribed as a long non-coding RNA (lncRNA)[1][4]. The 5′ sequence of GUSBP11 shares homology with the functional glucuronidase, beta (GUSB) gene, while the 3′ sequence relates to immunoglobulin lambda-like polypeptide 1[1]. Recent evidence demonstrates that GUSBP11 is significantly upregulated in lung adenocarcinoma, where it appears to promote tumor growth, proliferation, migration, and invasion through interaction with the RNA-binding protein KHSRP, thus participating in transcriptional regulation and oncogenic processes[2]. There is no evidence that GUSBP11 encodes a functional protein or that it acts as a direct therapeutic target such as a receptor or enzyme; its primary role is as a regulatory lncRNA with cancer-associated functions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucuronidase, beta pseudogene 11 (GUSBP11).